> Shares of PDI slid after the company announced that it is losing a $35 million sales contract. Release
> Bio Stem is acquiring Cryobanks International, obtaining nearly 9,000 internationally registered cord blood stem cell units being inventoried at their Altamore Springs, FL location. Release
> Chutes & Ladders: Gene Logic has tapped Charles L. Dimmler III to serve as president and chief executive; Richard Piazza has been named the new CEO at Chemokine. Report
> AstraZeneca has opened a $15 million process and development lab in Bangalore, India. Report
> Some powerful lawmakers have called on Amgen to halt all physician incentives related to its anemia drugs, Epogen and Aranesp, until an FDA committee has a chance to evaluate safety concerns. Report
> AEterna Zentaris announced that a clinical trial of its prostate drug cetrorelix demonstrated it was safe and well tolerated in Phase IIa. A Phase IIb for efficacy is being planned. Report
> Vion Pharmaceuticals has extended its manufacturing agreement with SAFC, a member of the Sigma-Aldrich Group, for its lead anticancer agent Cloretazine to September 2009. Report
And Finally... Eli Lilly is donating $50 million to help stamp out a highly virulent form of TB. Report